Response-Tailored Antibiotic Treatment for Endocarditis (POET II) @NEJMgroup
Response-Tailored Antibiotic Treatment for Endocarditis (POET II)  @NEJMgroup
Uploaded August 2026 | Updated September 2026, 1 week ago
Among adults with endocarditis caused by 𝘚. 𝘢𝘶𝘳𝘦𝘶𝘴, 𝘌. 𝘧𝘢𝘦𝘤𝘢𝘭𝘪𝘴, or streptococcus species, tailored-duration antibiotic therapy led to 13 more days alive without antibiotics than standard therapy, but with a higher incidence of relapse.

Read the full POET II trial results at NEJM.org.

#esccongress #cardiology #infectiousdisease #nejm | @EuropeanSocietyofCardiology
Response-Tailored Antibiotic Treatment for Endocarditis (POET II)NEJM This Week — April 2, 2026Teclistamab in Previously Treated Multiple Myeloma (MajesTEC-9)NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community...Ask the Expert: What’s the H2FPEF Score?Logistic Regression | NEJM EvidenceImage Challenge — July 23, 2026Original Article: Atezolizumab plus FOLFOX for Stage III Colon Cancer (ATOMIC)Dr. Glaucomflecken Explains: Clesrovimab for Prevention of RSV Disease in Healthy Infants (CLEVER)Images in Clinical Medicine: Bronchial Casts from Inhalation of Forest-Fire SmokeClinical Decisions: Operative versus Nonoperative Management for AppendicitisReview Article: GLP-1 Receptor Agonists
NEJM Group |

Response-Tailored Antibiotic Treatment for Endocarditis (POET II)

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER